When our embryos were labelled 'abnormal', we lost the right to choose
Fertility physician, clinical geneticist, and bioethicist Dr Shizuko Takahashi questions why PGT-A is being used to limit – rather than inform – patient choices...
Research Fellow, Centre for Biomedical Ethics
Dr Shizuko Takahashi is a Research Fellow at the Centre for Biomedical Ethics, at the National University of Singapore. She is trained in reproductive medicine and has worked as a certified Obstetrician, Gynecologist, and Clinical Geneticist at multiple hospitals in Tokyo. In 2011, she became the first physician to earn a PhD from the University of Tokyo's Department of Biomedical Ethics.
Her research is deeply interdisciplinary, encompassing domestic and international ethical regulations, government policies, public attitudes, and practices, with a strong focus on reproductive technologies. She has been an educator at the University of Tokyo and Yale University, teaching bioethics and medical ethics to students worldwide.
In addition to her academic work, Shizuko is also a children’s book writer and illustrator. She was awarded the Women's Challenge Award at the G7 ministerial meeting in Japan in 2023 for her book, The World Caught a Cold, which addresses the COVID-19 pandemic. Her recent projects continue to reflect her ongoing interest in genetics, reproductive medicine, and pediatrics.
Fertility physician, clinical geneticist, and bioethicist Dr Shizuko Takahashi questions why PGT-A is being used to limit – rather than inform – patient choices...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.